Measuring how arthritis patients respond to a common treatment - EurekAlert

Measuring how arthritis patients respond to a common treatment  EurekAlert

A new assay accurately measures how arthritis patients respond to treatment with the arthritis drug adalimumab, a finding that highlights potential strategies for ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases